$50.64
1.402.84%
마지막 업데이트: Oct 20, 2:52 PM
$50.88
1.643.33%
Benzinga
Benzinga
Benzinga
화요일, 10월 20
Benzinga
© 2026 Benzinga | All Rights Reserved
AnaptysBio (ANAB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.66 | $0.92 | $-1.17 |
| Actual | $-0.11 | $-1.84 | $1.58 | $0.52 |
| Surprise | +76.1% | -178.8% | +71.7% | +144.4% |
| Revenue | ||||
| Estimate | $21.7M | $18.9M | $86.0M | $25.6M |
| Actual | $27.5M | $25.6M | $108.2M | $76.3M |
| Surprise | +26.8% | +35.4% | +25.9% | +198.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.72 | $1.34 | $0.85 | $0.95 |
| Revenue | ||||
| Consensus | $33.2M | $49.0M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Sep 21, 2026 | $-0.11 | $-0.46 | 76.1 % |
| Q1 | May 12, 2026 | $-1.84 | $-0.66 | -178.8 % |
| Q4 | Mar 3, 2026 | $1.58 | $0.92 | 71.7 % |
| Q3 | Nov 4, 2025 | $0.52 | $-1.17 | 144.4 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Sep 21, 2026 | $27.49M | $21.68M | 26.8 % |
| Q1 | May 12, 2026 | $25.56M | $18.87M | 35.4 % |
| Q4 | Mar 3, 2026 | $108.24M | $85.96M | 25.9 % |
| Q3 | Nov 4, 2025 | $76.32M | $25.55M | 198.7 % |